These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7144291)

  • 1. [Vasodilator activity of cetiedil in patients with peripheral arterial insufficiency and vasospastic changes: hemodynamic study].
    Matesanz JM; Reina T; García F; Acin F; Méndez B; Tamames S
    Med Clin (Barc); 1982 Sep 1-15; 79(4):173-6. PubMed ID: 7144291
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
    Giulini SM; Agus GB; De Cristoforo A
    Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of vasodilators in peripheral arterial insufficiency].
    Hansteen V; Lorentsen E
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1731-4. PubMed ID: 5111131
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K; Sakuma M; Tanabe T
    Arzneimittelforschung; 1985; 35(7A):1198-200. PubMed ID: 4074434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical treatment of acute arterial obliteration in the limbs].
    Serradimigni A; Bory M; Poggi L; Audier M
    Rev Atheroscler (Paris); 1968; 10(2):3-8. PubMed ID: 5759950
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of pathogenetic treatment of arterial obliterative diseases of the extremities].
    Belokurov IuN; Rudnev NE
    Khirurgiia (Mosk); 1993 Feb; (2):15-8. PubMed ID: 8084143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic value of a new anti-ischemic and vaso-regulating drug: Cètièdil].
    Linquette M; Fossati P; Luez G
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1303-12. PubMed ID: 4802992
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological findings on cetiedil.
    Boissier JR; Aurousseau M; Giudicelli JF; Duval D
    Arzneimittelforschung; 1978; 28(12):2222-8. PubMed ID: 582934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasaprostan in everyday practice of vascular surgery department].
    Kokhan EP; Pinchuk OV; Batrashov VA
    Angiol Sosud Khir; 2003; 9(4):127-30. PubMed ID: 14657924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A trial of the use of Vasaprostan in patients with arteriosclerosis obliterans of the lower extremities].
    Lebedev LV; Dobrynin EV; Luk'ianov IuV; Ignat'ev EI; Afonin DN
    Vestn Khir Im I I Grek; 1993; 150(5-6):151-3. PubMed ID: 8091568
    [No Abstract]   [Full Text] [Related]  

  • 13. [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Bednarczyk-Kałuzna M
    Przegl Lek; 1982; 39(9):617-20. PubMed ID: 7178532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cormelian (Dilazep) a new coronary active substance].
    Reuter H
    Z Allgemeinmed; 1974 Oct; 50(28):1255-6. PubMed ID: 4614598
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ways to enhance the efficacy of treating patients with the terminal stage of arterial ischemia of the lower extremities].
    Lebedev LV; Afonin DN
    Vestn Khir Im I I Grek; 1995; 154(1):54-7. PubMed ID: 7792994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
    Prokhorov GG; Potapov VV; Ogneva NS; Zybina NN
    Vestn Khir Im I I Grek; 1994; 152(1-2):30-4. PubMed ID: 7701736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Denck H
    Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effectiveness of therapeutic measures in arterial occlusion disease].
    Koch A; Klett M; Hild R
    Dtsch Med J; 1970 May; 21(9):606-22. PubMed ID: 5481584
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic action of thymoxamine (an alpha-adrenergic blocking agent) in occlusive peripheral arterial disease.
    Myers KA; Hobbs JT; Irvine WT
    Cardiovasc Res; 1968 Oct; 2(4):360-6. PubMed ID: 4882442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.